AVITHRAPID
AVITHRAPID is a European flagship project co-funded by the European Commission and the Swiss Confederation, dedicated to accelerating antiviral innovation and strengthening Europe’s preparedness for future epidemics and pandemics.
Public Opinion Survey | Your voice is essential
Pandemics continue to influence public health, policy, and scientific priorities. To better understand how citizens, professionals, and institutions perceive these challenges - and what they expect from future preparedness efforts - AVITHRAPID is conducting a new international public opinion survey.
We invite researchers, healthcare professionals, policymakers, students, and citizens to participate.
The survey is anonymous, and you may request the final public report.
Learn how science, innovation, and collaboration protect us from future outbreaks.
researchers | innovators | organizations
Find out how to collaborate in antiviral research and development to accelerate the development of next-generation solutions.
Latest News & Events from AVITHRAPID
HPCSE 2026: Where Supercomputing Meets Pandemic Science
Held May 18–21 in the Beskydy Mountains (Czech Republic), HPCSE 2026 brought together leading experts in high-performance computing, applied mathematics, AI, and quantum computing under the banner of IT4Innovations National Supercomputing Center. Paulo Silva from IT4Innovations, partner of AVITHRAPID, attended
AVITHRAPID and Hantaviruses
Hantaviruses are a group of viruses carried by rodents such as mice and rats and transmitted through their droppings and urine. Hantaviruses are present throughout the world and can be found in parts of Europe, Africa, Asia, and South America.
AVITHRAPID at ICAR26
The International Society for Antiviral Research (ISAR) hosted the 39th International Conference on Antiviral Research (ICAR), bringing together leading scientists, researchers, and industry professionals to discuss the latest advancements and breakthroughs in antiviral research, from Monday, April 27th to Friday,